Related Experiment Video
Updated: Mar 14, 2026

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
Published on: November 8, 2016
PTEN ameliorates autoimmune arthritis through down-regulating STAT3 activation with reciprocal balance of Th17 and
Seung Hoon Lee1, Jin-Sil Park1, Jae-Kyung Byun1
1The Rheumatism Research Center, Catholic Research Institute of Medical Science, The Catholic University of Korea, Seoul, South Korea.
Abstract:
PTEN is a tyrosine phosphatase with significant function in inhibiting STAT3 activation. Recently, inactivation of STAT3 has been demonstrated as a therapeutic candidate for autoimmune arthritis. The expression of PTEN controlled by p53 regulates autoimmune arthritis through modulating the balance between Th17 and Treg. We hypothesized that PTEN regulated by p53 might reduce CIA severity and inflammatory response via inhibiting STAT3 activation. Our results revealed that PTEN could ameliorate experimental autoimmune arthritis by reducing STAT3 activity and Th17 differentiation. Systemic infusion of PTEN overexpression downregulated CIA severity. In addition, PTEN overexpression decreased the activation of T cells and modulated reciprocal differentiation of Th17 and Treg cells. We observed that PTEN expression downregulated by p53 deficiency induced the activation of STAT3. Loss of p53 exacerbated autoimmune arthritis and dysregulated the population of Th17 and Treg. These data suggest that induction of STAT3-modulatory activity of PTEN may be a therapeutic target for rheumatoid arthritis therapy.
Insights
PTEN protein, regulated by p53, ameliorates autoimmune arthritis by inhibiting STAT3 activation and Th17 cell differentiation. Loss of p53 exacerbates arthritis, highlighting PTEN
Area of Science:
- Immunology
- Molecular Biology
- Rheumatology
Background:
- Signal transducer and activator of transcription 3 (STAT3) inactivation is a therapeutic strategy for autoimmune arthritis.
- PTEN (phosphatase and tensin homolog) is a tyrosine phosphatase that inhibits STAT3 activation.
- PTEN expression, regulated by p53, influences the balance between Th17 and Treg cells in autoimmune arthritis.
Purpose of the Study:
- To investigate the role of p53-regulated PTEN in experimental autoimmune arthritis.
- To determine if PTEN ameliorates arthritis by inhibiting STAT3 activation and modulating T cell differentiation.
Main Methods:
- Overexpression of PTEN in a mouse model of collagen-induced arthritis (CIA).
- Assessment of CIA severity, T cell activation, and Th17/Treg cell populations.
- Evaluation of STAT3 activation in the context of p53 deficiency.
Main Results:
- Systemic PTEN overexpression reduced CIA severity and STAT3 activity.
- PTEN overexpression decreased T cell activation and modulated Th17/Treg cell balance.
- p53 deficiency led to decreased PTEN expression, increased STAT3 activation, exacerbated arthritis, and dysregulated Th17/Treg populations.
Conclusions:
- PTEN plays a protective role in autoimmune arthritis by inhibiting STAT3 activation and Th17 differentiation.
- p53-mediated regulation of PTEN is crucial for controlling autoimmune arthritis.
- Targeting the STAT3-modulatory activity of PTEN presents a potential therapeutic approach for rheumatoid arthritis.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The JAK-STAT Signaling Pathway
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...

